Revolution Medicines, Inc. · NASDAQ:RVMD
Dapice Joshua J. reported a 7.90% stake in Revolution Medicines, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed May 15, 2025
Dapice Joshua J. reported a 7.90% stake in Revolution Medicines, Inc., 13,262,045 shares, as a passive investor on Dec 31, 2024. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 7.90%
- Shares
- 13,262,045
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 30 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Farallon Capital Partners, L.P. | 0.50% | 894,594 |
| Farallon Capital Institutional Partners, L.P. | 0.70% | 1,179,934 |
| Farallon Capital Institutional Partners II, L.P. | 0.20% | 297,041 |
| Farallon Capital Institutional Partners III, L.P. | 0.10% | 133,463 |
| Four Crossings Institutional Partners V, L.P. | 0.10% | 204,302 |
| Farallon Capital Offshore Investors II, L.P. | 1.30% | 2,111,561 |
| Farallon Capital (AM) Investors, L.P. | 0.10% | 128,580 |
| Farallon Capital F5 Master I, L.P. | 0.30% | 421,785 |
| Farallon Healthcare Partners Master, L.P. | 4.70% | 7,890,785 |
| Farallon Partners, L.L.C. | 7.60% | 12,840,260 |
| Farallon Institutional (GP) V, L.L.C. | 0.10% | 204,302 |
| Farallon F5 (GP), L.L.C. | 0.30% | 421,785 |
| Farallon Healthcare Partners (GP), L.L.C. | 4.70% | 7,890,785 |
| Dapice Joshua J. | 7.90% | 13,262,045 |
| Dreyfuss, Philip D. | 7.90% | 13,262,045 |
| Dunn Hannah E. | 7.90% | 13,262,045 |
| Fried, Richard B | 7.90% | 13,262,045 |
| Gehani, Varun N. | 7.90% | 13,262,045 |
| Giauque, Nicolas | 7.90% | 13,262,045 |
| Kim, David T. | 7.90% | 13,262,045 |
| Linn, Michael G. | 7.90% | 13,262,045 |
| Luo Patrick (Cheng) | 7.90% | 13,262,045 |
| Patel, Rajiv A. | 7.90% | 13,262,045 |
| Roberts, Jr., Thomas G. | 7.90% | 13,262,045 |
| Saito Edric C. | 7.90% | 13,262,045 |
| Seybold, William | 7.90% | 13,262,045 |
| Short Daniel S. | 7.90% | 13,262,045 |
| Spokes, Andrew J. M. | 7.90% | 13,262,045 |
| Warren, John R. | 7.90% | 13,262,045 |
| Wehrly, Mark C. | 7.90% | 13,262,045 |
Source
Related
- Revolution Medicines, Inc.
- Dapice Joshua J.
- Revolution Medicines, Inc. shareholders
- Schedule 13G/A · Dapice Joshua J. · Feb 9, 2026
- Schedule 13G · Dapice Joshua J. · May 15, 2025
- Schedule 13G/A · Dapice Joshua J. · May 15, 2025
- Form 4 · Sandler Alan B. · Oct 1, 2026
- Form 4 · Cislini Jeff · Sep 29, 2026
- Form 4 · Mancini Anthony · Sep 28, 2026
- Form 4 · Anderson Elizabeth M · Sep 24, 2026
- Form 4 · Mancini Anthony · Sep 22, 2026